ArticleCancer communications (London, England)2025

Risk of colorectal cancer and cancer-related mortality in type 2 diabetes patients treated with metformin, SGLT-2 inhibitors, or their combination.

Xianhua Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.